Delivery Order SPE2DB24D2013-SPE2DB25FCJKF
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA), a Department of Defense (DoD) agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,958.67 and is a firm fixed-price delivery order that runs through June 21, 2024. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
The federal contract award is for the delivery of M-M-R II VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $9,615.50 and is a firm fixed price delivery order contract awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 11, 2025 and is not designated as a set-aside contract, indicating open competition....
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,155.60 and is a firm fixed-price delivery order with a completion date of March 11, 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,757.74. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 20, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of M-M-R II (Measles-Mumps-Rubella) vaccine vials to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,024.76 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,478.06 and a completion date of March 28, 2025. It is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award ceiling value is $1,084.38 and the contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5,...
This federal contract award is for the supply of M-M-R II (measles, mumps, and rubella) vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,024.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024 with a completion date of June 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award, valued at $8,386.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of M-M-R II vaccine vials, a childhood vaccine for measles, mumps, and rubella. This is a Firm Fixed Price delivery order contract with a period of performance through May 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen...